TECH & INNOVATION

Could Further Taxation on Fossil Fuels Complicate the Climate Change Issue?

While the conversation on the current and future changes in the climate are far from over, the United Nations (UN) has convened its discussion on the issue this week until the 2015 General Assembly that will be held in Paris. And as some nations felt unheard in their pleas at the Climate Summit held last Tuesday Sept. 23 in New York City, they’re turning up the heat on the global discourse looking for immediate solutions to the long-term problem.

Six Months of Ebola—Where the Virus has been and Where It’s Going

Six months ago, in a remote village of Guinea, a 2-year-old boy mysteriously fell ill of a hemorrhagic fever. Now, since the December 2013 outbreak, the disease has spread to the largest, most lethal Ebola epidemic in history. And it has yet to show any signs of cessation.

Australia Receives Backlash for Modest Goals at UN Summit

This week, as the United Nations (UN) held its annual General Assembly regarding global warming and the changing climate, all eyes and ears turned towards New York City, where celebrities, protestors and world leaders all came together for the unified goal of changing the Earth’s future. Though while all nations in attendance were open to the call for change, some found themselves vilified far before their history’s could be written in the record books.

Who’s the Predator And Who’s the Prey? Wyoming Fights Endangered Gray Wolves

It’s been a war brewing for the last few months, and Wyoming just entered its Hail Mary pass. Only a day after federal court judge Amy Berman Jackson of the Washington D.C. circuit announced that Gray Wolves would once again be inducted to the endangered species list, the state of Wyoming’s Game and Fish Commission appealed to the Secretary of State’s Office in hopes of commencing with its annual wolf-hunting season.

Rolapitant reduces nausea and vomiting in Phase III trial

Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain.

Recommended Stories